CITY MOVES | WHO’S SWITCHING JOBS

Nikko Asset Management
Nikko Asset Management Group, the largest regional asset manager headquartered in Asia, has appointed Eleanor Seet as president and executive director of Nikko Asset Management Asia. Seet will be responsible for leading the growth of Nikko AM in Singapore and Southeast Asia. Prior to joining the firm, Seet held the role of senior director, private wealth distribution, for iShares. Prior to that, she spent 12 years at AllianceBernstein, responsible for building the firm’s distribution channels.

Barings
Baring Asset Management has appointed John Burns as chief operating officer, taking over from John Misselbrook, who is retiring at the end of 2011 after a decade with the firm. Burns joins Barings from his role as chief operating officer at the boutique investment bank Visor Capital in Almaty, Kazakhstan.

BoA Merrill Lynch
Michel Sindelar will join Bank of America Merrill Lynch in January 2012 as head of CEEMEA emerging markets equities. Sindelar joins from Morgan Stanley, where he is a managing director and head of emerging markets equity product.

Ince & Co
The commercial law firm has appointed two Simon Cooper and Kiran Soar as partners in its insurance and reinsurance practice. Both join from Barlow Lyde & Gilbert.

Green Gas International BV
The producer of clean energy and carbon credits has announced that Joost Knoll will succeed Chris Norval as chief executive, effective from 1 December. Knoll formerly led the Hertel Group, where he became CEO in 2003.

MAM Funds
The multi-asset management group has appointed Tom Delic as an investment analyst at its Liverpool office. Delic was previously a technical analyst at Royal Liver Assurance and Mercers.

Cancer Research Technology
The commercial arm of Cancer Research UK has appointed Peter Chambré as its new chairman, to succeed Melanie Lee. Chambré is currently chairman of the private equity-backed pharmaceutical businesses Xellia Pharmaceuticals and 7TM Pharma.

Towergate Insurance
James Strachan has been appointed as an independent non-executive director and chairman of the group risk and compliance committee, subject to FSA approval. Strachan is currently a non-executive director of the FSA, JPMorgan Asian Investment, Welsh Water, Sarasin and Partners, and Social Finance Limited.